CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.

Biotechnology

CureVac

CureVac's headquarters in Tübingen, Germany

Alexander Zehnder

Myriam Mendila

Malte Greune

Dr. Marco Rau

Axel Sven Malkomes

Thaminda Ramanayake

Craig A. Tooman

Baron Jean Stéphenne

Birgit Hofmann

Mehdi Shahidi

The Quality Management Team at CureVac plays a critical role in ensuring that all processes and products meet stringent regulatory standards and industry best practices. This team oversees quality assurance, documentation, training, and compliance, facilitating seamless operations across the organization while ensuring the integrity and safety of CureVac's innovative mRNA therapies. Through effective management of quality agreements and material qualification, the team supports the overarching goal of delivering high-quality biopharmaceuticals to address various medical needs.

Quality Management Team

The Clinical Development Team at CureVac plays a pivotal role in advancing mRNA-based therapies through the design, execution, and oversight of clinical trials. Composed of experts in medical, regulatory, and operational domains, the team collaborates closely to ensure that innovative treatments are effectively translated from the laboratory to patient care while adhering to regulatory standards and optimizing trial efficiency. Their collective expertise drives the development of novel therapies targeting infectious diseases and beyond, ultimately contributing to CureVac’s mission of harnessing mRNA technology for transformative medical outcomes.

Clinical Development Team

The Leadership Team at CureVac is responsible for setting the strategic direction and ensuring operational excellence within the company. Comprising key executives such as the Chief Operating Officer, Chief Financial Officer, and Interim Chief Development Officer, this team collaborates to drive innovation in mRNA technology, optimize resource allocation, and oversee the development of novel therapeutic solutions, ultimately advancing the company's mission to combat various diseases through cutting-edge biopharmaceutical research.

Leadership Team

The Biophysical Chemistry and Analytics Team at CureVac is responsible for characterizing and optimizing the physical and chemical properties of mRNA molecules. They employ advanced analytical techniques to ensure the integrity and functionality of mRNA formulations, supporting the design and development of innovative therapies. By integrating data-driven insights, the team plays a crucial role in enhancing the efficacy and stability of mRNA-based products.

CureVac

Org chart

Board & advisors

Teams

Quality Management Team

Clinical Development Team

Leadership Team

Biophysical Chemistry and Analytics Team

Offices

CureVac

Org chart

Board & advisors

Teams

Quality Management Team

Clinical Development Team

Leadership Team

Biophysical Chemistry and Analytics Team

Offices

Related companies